Ten-year trends in neonatal assisted ventilation of very low-birthweight infants

Journal of Perinatology

Volumn 23, Issue 8, 2003, Pages 660-663

  Rich, Wade ^a   Finer, Neil N ^a,b   Vaucher, Yvonne E ^a  

^a UCSD MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; BIRTH WEIGHT; BLOOD GAS ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; INTUBATION; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN DEATH; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; NON INVASIVE MEASUREMENT; OXYGEN CONSUMPTION; PREDICTION; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

BIRTH WEIGHT; CHRONIC DISEASE; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; LUNG DISEASES; MALE; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0347588272     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7210995     Document Type: Article

References (19)

1. Synnes AR, Ling EWY, Whitfield MF, Mackinnon M, Lopes L, Wong G, Effer SB. Perinatal outcomes of a large cohort of extremely low gestational age infants (twenty-three to twenty-eight completed weeks of gestation). J Pediatr 1994;125(6 Part 1):952-60.
2. Wilson A, Gardner MN, Armstrong MA, Folck BF, Escobar GJ. Neonatal assisted ventilation: predictors, frequency, and duration in a mature managed care organization. Pediatrics 2000;105(4):822-30.
3. Perlstein PH, Atherton HD, Donovan EF, Richardson DK, Kotagal UR. Physician variations and the ancillary costs of neonatal intensive care. Health Serv Res 1997;32(3):299-311.
4. Barrington KJ, Bull D, Finer NN. Randomized trial of nasal synchronized intermittent mandatory ventilation compared with continuous positive airway pressure after extubation of very low birth weight infants. Pediatrics 2001;107(4):638-41.
5. Friedlich P, Lecart C, Posen R, Ramicone E, Chan L, Ramanathan R. A randomized trial of nasopharyngeal-synchronized intermittent mandatory ventilation versus nasopharyngeal continuous positive airway pressure in very low birth weight infants after extubation. J Perinatol 1999;19 (6 Part 1):413-8.
6. Khalaf MN, Brodsky N, Hurley J, Bhandari V. A prospective randomized, controlled trial comparing synchronized nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure as modes of extubation. Pediatrics 2001;108(1):13-7.
7. Lemyre B, Davis PG, De Paoli AG. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity (Cochrane Review). In: The Cochrane Library. Issue 1. Oxford: Update Software, 2003.
8. Rhodes PG, Graves GR, Patel DM, Campbell SB, Blumenthal BI. Minimizing pneumothorax and bronchopulmonary dysplasia in ventilated infants with hyaline membrane disease. J Pediatr 1983;103:634.
9. Mariani G, Cifuentes J, Carlo WA. Randomized trial of permissive hypercapnia in preterm infants. Pediatrics 1999;104(5):1082-8.
10. Carlo WA, Stark AR, Wright LL et al. Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-low-birth-weight infants. J Pediatr 2002;141(3):370-5.
11. Majnemer A, Riley P, Shevell M, Birnbaum R, Greenstone H, Coates AL. Severe bronchopulmonary dysplasia increases risk for later neurological and motor sequelae in preterm survivors. Dev Med Child Neurol 2000;42(1):53-60.
12. Vohr BR, Wright LL, Dusick AM, et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-94. Pediatrics 2000;105:1216-26.
13. D'Angio CT, Sinkin RA, Stevens TP et al. Longitudinal, 15-year follow-up of children born at less than 29 weeks' gestation after introduction of surfactant therapy into a region: neurologic, cognitive, and educational outcomes. Pediatrics 2002;110(6):1094-102.
14. Schmidt B, Asztalos EV, Roberts RS, Robertson CMT, Sauve RS, Whitfield MF. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months - results from the trial of indomethacin prophylaxis in preterms. JAMA J Am Med Assoc 2003;289(9):1124-9.
15. Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, OShea TM. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. Pediatrics 1999;104(6):1345-50.
16. VanMarter LJ, Dammann O, Allred EN et al. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 2002;140(2):171-6.
17. Hamvas A, Devine T, Cole FS. Surfactant therapy failure identifies infants at risk for pulmonary mortality. Am J Dis Child 1993;147(6):665-8.
18. Peliowski A, Finer NN, Etches PC, Tierney AJ, Ryan CA. Inhaled nitric oxide for premature infants after prolonged rupture of the membranes. J Pediatr 1995;126(3):450-3.
19. The Franco-Belgium Collaborative Trial Group. Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial. Lancet 199;354:1066-71.